Acquisitions, de novos, integration, EBITDA, and enterprise value creation.
Thoreau, the healthcare investment platform launched by former New Mountain Capital private equity president Matt Holt, has agreed to make a strategic growth investment in Ensemble Health Partners,…
Deacon Associates has agreed to acquire 31 home health and hospice agencies from HCA Healthcare, with hospice representing 23% of the divested assets across eight states. The deal,…
Becker’s Dental Review’s May 2026 roundup identifies several states with notable DSO activity, led by Arizona, Colorado, New York, and Texas. In Arizona, PDS Health opened a new…
Behavioral health M&A recorded 42 closed transactions in Q1 2026 — 34 traditional M&A deals and 8 growth financings totaling $535.7 million. Mental health led with 19 deals,…
Dental M&A has rebounded strongly in 2026 after a slowdown driven by elevated capital costs, enhanced due diligence, and unrealistic seller valuations. DSOs are aggressively expanding across specialties…
Physician group private equity deal volume fell from 28% of global provider transactions in 2021 to 23% in 2025, per Bain & Company’s 2026 Global Healthcare Private Equity…
Sixty-nine percent of DSOs expect their private equity sponsors to push for moderate-to-high increases in acquisition activity in 2026, according to TUSK Practice Sales’ Q2 2026 Dental Market…
De novo healthcare locations routinely underperform in their first months because media plans launch too late—often just weeks before opening, when the algorithm still needs time to learn….
Behavioral health M&A in 2026 is running slower than expected but deal activity continues. SUD treatment may be the most undervalued subsector, with deal flow at a six-year…
Ambulatory surgery center M&A remains active in 2026, with private equity and health systems both accelerating acquisition pace. Tenet Healthcare’s USPI deployed $125 million in Q1 2026 alone…
